Minimally Invasive Glaucoma Surgery: iStent and Preserflo in the Treatment of Primary Open-Angle Glaucoma. A Review
Czech and Slovak Ophthalmology · 10.10.2025
DOI: 10.31348/2025/39 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Czech and Slovak Ophthalmology, online erschienen am 10.10.2025. Verfasst von Richard Ulrych und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Glaucoma, Open-Angle, Glaucoma Drainage Implants.
Abstract (Originalsprache)
Glaucoma is a chronic, progressive and irreversible neuropathy of the optic nerve, characterized by morphological changes in the optic nerve papilla and defects in the visual field. Although the precise pathogenesis is not fully understood, the current concept of glaucoma development incorporates the deformation of the lamina cribrosa caused by elevated intraocular pressure, leading to axonal damage, subsequent apoptosis of retinal ganglion cells and loss of the nerve fiber layer. This review article discusses the current possibilities of using minimally invasive glaucoma surgery, specifically focusing on the micro-invasive implants iStent and Preserflo, their efficacy and safety in the surgical treatment of primary open-angle glaucoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Ulrych, R., & Stěpanov, A. (2025). Minimally Invasive Glaucoma Surgery: iStent and Preserflo in the Treatment of Primary Open-Angle Glaucoma. A Review. Czech and Slovak Ophthalmology. https://doi.org/10.31348/2025/39
Vancouver
Ulrych R, Stěpanov A. Minimally Invasive Glaucoma Surgery: iStent and Preserflo in the Treatment of Primary Open-Angle Glaucoma. A Review. Czech and Slovak Ophthalmology. 2025. doi:10.31348/2025/39
BibTeX
@article{Ulrych2025,
author = {Ulrych, Richard and Stěpanov, Alexandr},
title = {Minimally Invasive Glaucoma Surgery: iStent and Preserflo in the Treatment of Primary Open-Angle Glaucoma. A Review},
journal = {Czech and Slovak Ophthalmology},
year = {2025},
doi = {10.31348/2025/39}
}
EUVIMED